Drugs / Bactrim DS
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | BACTRIM | — | 1973-07-30 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07561541 | Apr 2026 → Dec 2027 expected | diabetes mellitus | Texas Tech University Health Sciences Center, El Paso | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bactrim DS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07561541 ↗ |